MediWound (NASDAQ: MDWD)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.110 | -0.120 | -0.0100 | ||||
REV | 4.290M | 4.407M | 117.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of MediWound (NASDAQ: MDWD) through any online brokerage.
There are no as such competitors for MediWound.
The latest price target for MediWound (NASDAQ: MDWD) was reported by Wells Fargo on Wednesday, May 18, 2022. The analyst firm set a price target for 8.00 expecting MDWD to rise to within 12 months (a possible 403.14% upside). 4 analyst firms have reported ratings in the last year.
The stock price for MediWound (NASDAQ: MDWD) is $1.59 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for MediWound.
MediWound’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for MediWound.
MediWound is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.